Reversible istradefylline-induced pleurothotonus in a patient with Parkinson's disease: A case report and literature review

Ekbom, 1972, New dystonic syndrome associated with butyrophenone therapy, Z Neorol, 202, 94, 10.1007/BF00316159 Vanacore, 2005, Pisa syndrome in a cohort of Alzheimer's disease patients, Acta Neurol Scand, 111, 199, 10.1111/j.1600-0404.2005.00388.x Colosimo, 1998, Pisa syndrome in a patient multiple system atrophy, Mov Disord, 13, 607, 10.1002/mds.870130342 Cannas, 2005, Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide. A case report, Clin Neuropharmacol, 28, 252, 10.1097/01.wnf.0000183449.04271.05 A. Cannas, P. Solla, G. Floris et al, Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy. J Neurol 256 (2009) 390–395. Gambarian, 2006, Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease; Case report, Mov. Disor, 21, 270, 10.1002/mds.20711 Solla, 2008, Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient, J Neurol Sci, 275, 154, 10.1016/j.jns.2008.07.017 Fasano, 2011, Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy, Mov. Disord, 26, 2578, 10.1002/mds.23918 Galati, 2014, Ropinirole-induced Pisa syndrome in Parkinson disease, Clin Neuropharmacol, 37, 58, 10.1097/WNF.0000000000000022 Kulisevsky, 2012, Adenosine A2A -receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders, Eur Neurol, 67, 4, 10.1159/000331768